Human Reproductive Technologies Market is witnessing robust growth with Ferring Pharmaceuticals collaborating with Rebiotix Inc. and MyBiotics Pharma Ltd. to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women

 

Human Reproductive Technologies Market

Human Reproductive Technologies is the use of science to help in the process of reproduction. The term Human Reproductive Technologies covers all medical interventions that are used to help people have children. The market for Human Reproductive Technologies is very large and there are many aspects that affect the marketability of a product. The overall costs of such procedures may vary from country to country and may also depend upon the techniques that are being used to perform the procedure. There is a high rate of infertility in North America due to high obesity rates, which is leading to the increased adoption of human reproductive technologies. As per the Centers for Disease Control and Prevention (CDC), in 2021, around 40% of adults aged 20 to 39 years were obese. On the contrary, Asia Pacific is gaining significant traction in the human reproductive technologies market since there is a high population coupled with growing awareness regarding reproductive technologies.

The adoption of advanced human reproductive technologies has increased over the years across the globe. Since the cases of infertility are rising, the demand for effective reproductive technologies is likely to increase. As per the World Health Organization (WHO), in 2020, around 48 million couples and 186 million individuals live were with infertility across the globe. Such high prevalence necessitates proper treatment options. Thus, such factors can stimulate growth of the human reproductive technologies market.

That being said, there are certain challenges that could limit the adoption of human reproductive technologies with limited insurance coverage being the one. Besides, there is low adoption of human reproductive technologies in emerging economies, which could potentially inhibit growth of the human reproductive technologies market in the near future.

Another major area that the reproductive technologies industry is currently focusing on is the treatment of infertility caused by various factors. These factors range from age to genetics and can be a very complicated problem that is why most doctors recommend their patients to go under the care of an expert in the field. Infertility treatments like in vitro fertilization or intrauterine insemination are fast rising and have helped couples to have children despite being infertile. Another key factor that has led to the high adoption of reproductive technologies is rising prevalence of maternal mortality. As per the WHO, in 2017, around 810 women died from preventable causes related to childbirth and pregnancy. Such factors and lead to high demand for effective treatment methods and augment growth of the human reproductive technologies market. 

Recently, in February 2021, Ferring Pharmaceuticals collaborated with Rebiotix Inc. and MyBiotics Pharma Ltd. to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women.


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

The market for ureteral stents would benefit from the rising prevalence of urological diseases

The North America Vision Care Market Is Driven by the Increasing Prevalence of Eye Diseases in this Region